Showing results (221-230 of 305) with videos related to
Sort By:
Pageof 31
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|January 31, 2012
Impact of verbal explanation and modified consent materials on orthodontic informed consentKelly M Carr, Henry W Fields, F Michael Beck, et al.Molecular Genetics and Metabolism Reports|March 4, 2016
Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysisMichael Beck, Derralynn Hughes, Christoph Kampmann, et al.Human Molecular Genetics|February 18, 2003
Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmoninDominique Weil, Aziz El-Amraoui, Saber Masmoudi, et al.Journal of Inherited Metabolic Disease|October 23, 2024
Natural history of valve disease in patients with mucopolysaccharidosis II and the impact of enzyme replacement therapyChristoph Kampmann, Christina Lampe, Christiane M Wiethoff, et al.Scientific Reports|June 13, 2020
Individual Calculation of Effective Dose and Risk of Malignancy Based on Monte Carlo Simulations after Whole Body Computed TomographyMarkus Kopp, Tobias Loewe, Wolfgang Wuest, et al.Neurology|February 10, 2015
Thromboembolic events in Fabry disease and the impact of factor V LeidenMalte Lenders, Nesrin Karabul, Thomas Duning, et al.Head & Neck|December 2, 2005
Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progressionParish P Sedghizadeh, Susan R Mallery, Sarah J Thompson, et al.International Journal of Colorectal Disease|July 4, 2018
Repeating of local therapy of distant metastases increases overall survival in patients with synchronous metastasized rectal cancer-a monocentric analysisMarlen Haderlein, Sebastian Lettmaier, Melanie Langheinrich, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
Impact of measures to enhance the value of observational surveys in rare diseases: the Fabry Outcome Survey (FOS)Joe T R Clarke, Roberto Giugliani, Gere Sunder-Plassmann, et al.European Journal of Human Genetics : EJHG|April 18, 2006
Differences in methylation patterns in the methylation boundary region of IDS gene in Hunter syndrome patients: implications for CpG hot spot mutationsShunji Tomatsu, Kazuko Sukegawa, Georgeta G Trandafirescu, et al.Pageof 31